Ligliptin for treatment of type 2 diabetes mellitus with early renal injury: Efficacy and impact on endogenous hydrogen sulfide and endothelial function

doi:10.12998/wjcc.v8.i10.1878

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5391)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

242

WORD

164

HTML

2633

Figures (1-3)

232

Tables (1-5)

256

Sum=3527

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

689

Download

1175

Sum=1864

May 26, 2020 (publication date) through Aug 29, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. May 26, 2020; 8(10): 1878-1886
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1878

Table 3 Comparison of renal function indexes between the two groups before and after treatment

	Ligliptin treatment group	Gliquidone treatment group	P value
Number of cases	54	56
UAER (μg/min)
Before treatment	110.21 (18.82)	107.82 (20.11)	0.522
After treatment	70.32 (11.21)^a	88.42 (12.27)^a	0.000
BUN (mmol/L)
Before treatment	6.10 (1.12)	6.05 (1.09)	0.813
After treatment	5.77 (1.04)^a	5.79 (1.21)^a	0.926
Cr (μmol/L)
Before treatment	110.38 (15.56)	108.82 (18.81)	0.637
After treatment	108.02 (12.38)	107.22 (11.87)	0.730
CysC (mg/L)
Before treatment	1.74 (0.30)	1.78 (0.33)	0.508
After treatment	1.65 (0.33)^a	1.67 (0.35)^a	0.759

^aP < 0.05 vs before treatment. UAER: Urinary albumin excretion rate; BUN: Blood urea nitrogen; Cr: Creatinine; CysC: Cystatin C.

Citation: Zhang J, Du YL, Zhang H, Sui H, Hou WK. Ligliptin for treatment of type 2 diabetes mellitus with early renal injury: Efficacy and impact on endogenous hydrogen sulfide and endothelial function. World J Clin Cases 2020; 8(10): 1878-1886
URL: https://www.wjgnet.com/2307-8960/full/v8/i10/1878.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i10.1878